About: Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 December 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) artículu científicu espublizáu n'avientu de 2019 (ast) scientific article published on 17 December 2019 (en) наукова стаття, опублікована 17 грудня 2019 (uk)
publication date	wds:Q92713292-55FB9E20-DA51-47B0-991B-33BDA1916995
publication date	2019-12-17 00:00:00Z (xsd:dateTime)
cites work	wds:Q92713292-03615536-E5D5-4EF6-B0F9-5E0CE1EC867E wds:Q92713292-187866B3-E900-4A71-8C2E-315B0A1411E2 wds:Q92713292-1DD16381-7E08-400C-9295-3BD76BB88231 wds:Q92713292-2C0208D5-A78B-4365-B1CA-13FC27065BED wds:Q92713292-2FE54B4F-945D-4733-9C6B-4C0C5A22CD49 wds:Q92713292-3230D580-B470-48BC-9BF9-B5CA39B2B324 wds:Q92713292-3BF2C54F-9C10-4A2F-9240-D3D46F905588 wds:Q92713292-4B36AC17-48BD-433B-9B58-C7B9DAD7C2D9 wds:Q92713292-4B587C20-8516-48C0-877F-CDDDDE624073 wds:Q92713292-4F5354FA-63EA-4D1F-95E8-BA5EB4AB6E4F wds:Q92713292-57EB0F09-6851-45DA-8E9C-8730376C6556 wds:Q92713292-6D55E64B-EFEE-4993-8C71-935C072517F6 wds:Q92713292-713F1E53-96C4-4E38-B0BF-FF6AB61CDC59 wds:Q92713292-71C98A1D-18BE-4891-9EAE-9398940DEB08 wds:Q92713292-7C113200-735D-4BA6-9D06-DF4CDE7AAA68 wds:Q92713292-7CEB3673-1107-4BB4-8AB1-E1E53479C526 wds:Q92713292-8063A165-75AF-4ACE-9A72-30F17F9DFF86 wds:Q92713292-8383447E-AB49-49F5-B2EA-EFE3682914D8 wds:Q92713292-880BA948-C4C6-4950-B593-D37A9C4B5F31 wds:Q92713292-90B7AE00-566F-461B-98C4-92DDBF5D3501 wds:Q92713292-93DB4710-26D8-4A46-A084-FC6DF36ED178 wds:Q92713292-9DEF3557-2F93-442D-AC95-2A4857CAA6A3 wds:Q92713292-A6610895-3D3D-4033-9F8F-458ABD70F4A0 wds:Q92713292-A7274288-AA46-4587-8CB5-02097852D3A3 wds:Q92713292-A98D3328-E2EB-4FBC-A57D-AD35F0B43F07 wds:Q92713292-B7822078-08B3-42BA-B8D1-96A8B4FD03BF wds:Q92713292-BA5A324F-C78F-4761-A46A-5341629BDA72 wds:Q92713292-C3FBCBAE-45FB-42D7-81BF-16FA2E3BC7E9 wds:Q92713292-E3967735-0E9B-4B03-931A-15C92402EBF2 wds:Q92713292-EDBD89C3-07D5-46F8-B235-3D4B140740E3 wds:Q92713292-FA7E4AB9-97B4-4ED6-B4C2-B90DDC6B66A3 wds:Q92713292-FE763CB1-1F6F-4FCE-8D52-3657B3A90541
cites work	Follicular helper CD4 T cells (TFH) Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements High DNA-binding activity of transcription factor NF-kappa B in synovial membranes of patients with rheumatoid arthritis Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis Rheumatoid arthritis. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti-TNF-α Antibodies after a Single Injection in Mice Efficacy of adjunct tacrolimus treatment in patients with rheumatoid arthritis with inadequate responses to methotrexate. Inhibitory effect of tacrolimus on progression of joint damage in patients with rheumatoid arthritis. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis Pathogenetic insights from the treatment of rheumatoid arthritis FK506 suppresses the stimulation of matrix metalloproteinase 13 synthesis by interleukin-1beta in rheumatoid synovial fibroblasts Nuclear factor-kappa B activity in T cells from patients with rheumatic diseases: a preliminary report. The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab. Increased nuclear factor-kappaB activation in peripheral blood monocytes of patients with rheumatoid arthritis is mediated primarily by tumor necrosis factor-alpha TNFα blockade mediates bone protection in antigen-induced arthritis by reducing osteoclast precursor supply Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan.
author name string	wds:Q92713292-02DAF411-8C57-4EF4-8426-43F4052E8C2C wds:Q92713292-33AB507C-1869-4FE0-9E03-7A613D2EF679 wds:Q92713292-540CDD5C-85D6-4712-9819-855D162B3165 wds:Q92713292-A4179E57-699D-4E79-9190-AFA7510A587A wds:Q92713292-B12D64E5-EF43-4FE0-9E64-6BED0DCBD936 wds:Q92713292-E61981E8-871D-4C16-8366-44D28C74A39B
author name string	Hiroyuki Aono Minoru Sasano Hiroaki Matsuno Miwa Takai-Imamura Satoshi Shirae Tomomi Kohara-Tanaka
rdfs:label	Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice (en) Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice (nl)
skos:prefLabel	Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice (en) Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice (nl)
name	Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice (en) Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice (nl)
author	wds:Q92713292-02A977A7-E01C-4115-A00F-D568924C2FD1
author	Iwao Seki
title	wds:Q92713292-56001D50-4A68-4E4B-8EBF-A9B440918A3B
title	Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice (en)
page(s)	wds:Q92713292-3E296971-3F6E-4284-802C-82EFF8CFF7A5
page(s)	4176974
instance of	wds:Q92713292-8E73BB89-A6F3-4C07-819B-1692ABD51824
instance of	scholarly article
PubMed ID	wds:Q92713292-909139EB-6115-4020-A672-02BE388D1A5E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31949424

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software